Dolby Laboratories (NYSE:DLB) SVP John Couling Sells 7,666 Shares

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,666 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the completion of the sale, the senior vice president owned 118,353 shares of the company’s stock, valued at $6,811,215.15. This trade represents a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Dolby Laboratories Price Performance

DLB traded down $0.93 during trading hours on Wednesday, reaching $58.11. The company’s stock had a trading volume of 768,602 shares, compared to its average volume of 747,274. Dolby Laboratories has a fifty-two week low of $55.73 and a fifty-two week high of $78.28. The stock has a market cap of $5.55 billion, a PE ratio of 22.97 and a beta of 0.86. The business’s 50-day moving average is $62.48 and its 200-day moving average is $64.42.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The firm had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. During the same period in the prior year, the firm posted $1.34 earnings per share. The firm’s quarterly revenue was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Analysts expect that Dolby Laboratories will post 3.17 EPS for the current year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be issued a $0.36 dividend. The ex-dividend date is Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.5%. Dolby Laboratories’s dividend payout ratio is currently 56.92%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, April 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Finally, Rosenblatt Securities restated a “buy” rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $90.75.

Institutional Trading of Dolby Laboratories

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. raised its stake in shares of Dolby Laboratories by 2.7% in the third quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after acquiring an additional 203,411 shares in the last quarter. State Street Corp raised its stake in shares of Dolby Laboratories by 8.7% in the second quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after acquiring an additional 180,072 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Dolby Laboratories by 15.6% in the fourth quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after acquiring an additional 254,250 shares in the last quarter. First Trust Advisors LP raised its stake in shares of Dolby Laboratories by 23.8% in the fourth quarter. First Trust Advisors LP now owns 1,880,528 shares of the electronics maker’s stock valued at $120,768,000 after acquiring an additional 361,871 shares in the last quarter. Finally, AQR Capital Management LLC raised its stake in shares of Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares in the last quarter. 58.56% of the stock is currently owned by institutional investors and hedge funds.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.